[Desirudine (Revasc): preventive therapy for deep venous thrombosis].
Andréjak
M
M
Service de Pharmacologie, CHU Sud, Amiens. pharmacovigilance@chu-amiens.fr
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006406:Hematoma / Q000517:prevention & control; D006470:Hemorrhage / Q000517:prevention & control; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives*; D006801:Humans; D011655:Pulmonary Embolism / Q000517:prevention & control; D011994:Recombinant Proteins / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000150:complications / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006629:Hirudins; D011994:Recombinant Proteins; C060225:desirudin
Désirudine (Revasc): un traitement préventif des thromboses veineuses profondes.